TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.10$ +0.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Xilio Development Inc (XLO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 155 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XLO
Line item 2019 2020 2021 2022 2023 2024 2025
63 36 222 139 61 71 155
51 21 203 124 48 60 145
49 19 198 120 45 55 138
49 19 198 120 45 55 138
– – 0.4 0.3 – – 5.0
9.9 14 14 7.3 – – –
24 42 36 34 24 53 119
5.2 22 13 21 16 27 56
– 3.0 0.9 7.6 4.4 1.2 1.3
2.5 5.4 3.1 3.1 1.1 2.6 3.2
9.6 7.4 9.6 3.2 – – –
39 -5.3 185 106 37 18 35
-30 -85 -161 -249 -326 -384 -419
0.0 0.0 0.4 27 2.0 3.8 84

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?